Location History:
- Lyons, FR (2015)
- Lyon, FR (2015)
Company Filing History:
Years Active: 2015
Title: Bernard Ferrier: Innovator in Insulin Resistance Treatment
Introduction
Bernard Ferrier is a notable inventor based in Lyon, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of insulin resistance. With a focus on innovative compounds, Ferrier has been instrumental in developing solutions for serious health conditions.
Latest Patents
Ferrier holds 2 patents related to piperazine derivatives. His latest patents include methods for preparing these compounds and their uses in treating insulin resistance syndrome, particularly type 2 diabetes. The first patent discloses compounds and compositions that are useful in addressing pathologies associated with insulin resistance syndrome. The second patent details a specific compound of formula (I), along with methods for its preparation and pharmaceutical compositions containing it.
Career Highlights
Ferrier is associated with Metabolys, a company dedicated to advancing medical treatments. His work has focused on creating effective therapies for conditions linked to insulin resistance, showcasing his commitment to improving patient outcomes.
Collaborations
Throughout his career, Ferrier has collaborated with notable colleagues such as Gérard Moinet and Gabriel Baverel. These partnerships have contributed to the advancement of his research and the development of innovative treatments.
Conclusion
Bernard Ferrier's contributions to the field of pharmaceuticals, particularly in the treatment of insulin resistance, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.